Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
J Synchrotron Radiat. 2022 Jan 1;29(Pt 1):125-137. doi: 10.1107/S1600577521011140.
Successful transition of synchrotron-based microbeam radiation therapy (MRT) from pre-clinical animal studies to human trials is dependent upon ensuring that there are sufficient and adequate measures in place for quality assurance purposes. Transmission detectors provide researchers and clinicians with a real-time quality assurance and beam-monitoring instrument to ensure safe and accurate dose delivery. In this work, the effect of transmission detectors of different thicknesses (10 and 375 µm) upon the photon energy spectra and dose deposition of spatially fractionated synchrotron radiation is quantified experimentally and by means of a dedicated Geant4 simulation study. The simulation and experimental results confirm that the presence of the 375 µm thick transmission detector results in an approximately 1-6% decrease in broad-beam and microbeam peak dose. The capability to account for the reduction in dose and change to the peak-to-valley dose ratio justifies the use of transmission detectors as thick as 375 µm in MRT provided that treatment planning systems are able to account for their presence. The simulation and experimental results confirm that the presence of the 10 µm thick transmission detector shows a negligible impact (<0.5%) on the photon energy spectra, dose delivery and microbeam structure for both broad-beam and microbeam cases. Whilst the use of 375 µm thick detectors would certainly be appropriate, based upon the idea of best practice the authors recommend that 10 µm thick transmission detectors of this sort be utilized as a real-time quality assurance and beam-monitoring tool during MRT.
成功地将基于同步加速器的微束放射治疗(MRT)从临床前动物研究过渡到人体试验,取决于确保有足够和充分的质量保证措施。透射探测器为研究人员和临床医生提供了实时的质量保证和束流监测仪器,以确保安全和准确的剂量输送。在这项工作中,通过专门的 Geant4 模拟研究,实验和定量地研究了不同厚度(10μm 和 375μm)的透射探测器对空间分割的同步加速器辐射的光子能谱和剂量沉积的影响。模拟和实验结果证实,375μm 厚的透射探测器的存在导致宽束和微束峰值剂量降低约 1-6%。能够考虑到剂量的减少和峰值到谷值剂量比的变化, justifies 使用厚度达 375μm 的透射探测器,只要治疗计划系统能够考虑到它们的存在。模拟和实验结果证实,对于宽束和微束情况,10μm 厚的透射探测器的存在对光子能谱、剂量输送和微束结构几乎没有影响(<0.5%)。虽然使用 375μm 厚的探测器肯定是合适的,但基于最佳实践的想法,作者建议在 MRT 期间使用这种 10μm 厚的透射探测器作为实时质量保证和束流监测工具。